Target- |
Mechanism- |
|
|
|
Inactive Indication- |
Drug Highest PhaseApproved |
First Approval Ctry. / Loc.CN |
First Approval Date27 Apr 2020 |
Target- |
Mechanism- |
|
|
|
Inactive Indication- |
Drug Highest PhaseApproved |
First Approval Ctry. / Loc.CN |
First Approval Date24 Apr 2020 |
100 Clinical Results associated with Tianjin Darentang No. 2 Pharmaceutical Factory Co. Ltd.
0 Patents (Medical) associated with Tianjin Darentang No. 2 Pharmaceutical Factory Co. Ltd.
100 Deals associated with Tianjin Darentang No. 2 Pharmaceutical Factory Co. Ltd.
100 Translational Medicine associated with Tianjin Darentang No. 2 Pharmaceutical Factory Co. Ltd.